Profund Advisors LLC Biomea Fusion, Inc. Transaction History

Profund Advisors LLC

  • $2.59 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$13.92 - $19.5 $784,392 - $1.1 Million
56,350 Added 340.96%
72,877 $1.09 Million
Q4 2023

Feb 14, 2024
SELL
$8.37 - $19.8 $187,178 - $442,787
-22,363 Reduced 57.5%
16,527 $239,000
Q3 2023

Nov 13, 2023
BUY
$13.44 - $23.02 $190,538 - $326,354
14,177 Added 57.37%
38,890 $535,000
Q2 2023

Aug 10, 2023
BUY
$21.66 - $41.8 $535,283 - $1.03 Million
24,713 New
24,713 $542,000

Others Institutions Holding BMEA

# of Institutions
104
Shares Held
17.9M
Call Options Held
1.68M
Put Options Held
410K
View Full List

About Biomea Fusion, Inc.

BMEA Quotes by TradingView
  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $115M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Profund Advisors LLC Portfolio

Follow Profund Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Profund Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Profund Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email